General Information of the Compound
| Compound ID |
CP0259117
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R)-N-(adamantan-2-yl)-1-ethylpyrrolidine-2-carboxamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
(1S,2R)-N-(2-adamantyl)-1-ethyl-pyrrolidine-2-carboxamide
(2R)-N-(adamantan-2-yl)-1-ethylpyrrolidine-2-carboxamide
1-ethyl-N-[(1R,3S,5R,7R)-tricyclo[3.3.1.1~3,7~]dec-2-yl]-D-prolinamide
BDBM50317209
CHEMBL1095047
N-2-adamantyl-1-ethyl-D-prolinamide
N-Adamantan-2-Yl-1-Ethyl-D-Prolinamide
PF-877423
SCHEMBL5157584
UJRJQNDIYCDCNX-BAPHQMLMSA-N
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H28N2O
|
||||||||||||||||||
| Molecular Weight |
276.424
|
||||||||||||||||||
| Canonical SMILES |
CCN1CCC[C@@H]1C(=O)NC1C2CC3CC(C2)CC1C3
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H28N2O/c1-2-19-5-3-4-15(19)17(20)18-16-13-7-11-6-12(9-13)10-14(16)8-11/h11-16H,2-10H2,1H3,(H,18,20)/t11?,12?,13?,14?,15-,16?/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UJRJQNDIYCDCNX-BAPHQMLMSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound